$AYTU
AYTU BIOPHARMA, INC Stock $aytu

$aytu Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000143774924030062 Filed on September 26, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue	$16.57M	$17.98M	$81.00M
YoY Change	-25.0%	-41.5%	-24.58%
Cost Of Revenue	$4.589M	$6.070M	$26.42M
YoY Change	-37.27%	-50.12%	-35.2%
Gross Profit	$11.99M	$11.91M	$54.59M
YoY Change	-18.93%	-35.85%	-18.08%
Gross Profit Margin	72.31%	66.23%	67.39%
Selling, General & Admin	$10.78M	$11.09M	$49.47M
YoY Change	-25.0%	-21.36%	-29.4%
% of Gross Profit	89.98%	93.13%	90.63%
Research & Development	$426.0K	$1.044M	$2.791M
YoY Change	-29.47%	122.13%	-31.84%
% of Gross Profit	3.55%	8.77%	5.11%
Depreciation & Amortization	$1.427M	$1.944M	$8.272M
YoY Change	-36.01%	-8.3%	-6.16%
% of Gross Profit	11.91%	16.33%	15.15%
Operating Expenses	$12.92M	$13.43M	$59.84M
YoY Change	-20.71%	-12.07%	-28.5%
Operating Profit	-$930.0K	-$1.529M	-$5.254M
YoY Change	-38.16%	-146.62%	-69.21%
Interest Expense	$2.428M	$322.0K	-$8.228M
YoY Change	-136.68%	-112.24%
% of Operating Profit
Other Income/Expense, Net	$542.0K		$568.0K
YoY Change	-108.19%		3957.14%
Pretax Income	$1.498M	-$3.922M	-$14.08M
YoY Change	-118.45%	59.43%	-17.45%
Income Tax	$405.0K	$695.0K	$1.768M
% Of Pretax Income	27.04%
Net Earnings	$1.474M	-$4.617M	-$15.84M
YoY Change	-118.2%	87.68%	-7.35%
Net Earnings / Revenue	8.89%	-25.68%	-19.56%
Basic Earnings Per Share	$0.24		-$2.86
Diluted Earnings Per Share	-$0.15	-$0.82	-$2.86
COMMON SHARES
Basic Shares Outstanding	6.149M	5.568M	5.538M
Diluted Shares Outstanding	9.100M

Balance Sheet

Concept	2024 Q3	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.11M	$20.01M	$20.01M
YoY Change	0.54%	-13.02%	-13.02%
Cash & Equivalents	$20.11M	$20.01M	$20.01M
Short-Term Investments
Other Short-Term Assets	$60.74M	$61.89M	$5.635M
YoY Change	8009.21%	7030.3%	-36.69%
Inventory	$11.74M	$12.63M	$12.63M
Prepaid Expenses	$5.732M	$5.635M
Receivables	$23.16M	$23.62M	$23.62M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$60.74M	$61.89M	$61.89M
YoY Change	-13.97%	-15.02%	-14.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$692.0K	$693.0K	$1.522M
YoY Change	-83.52%	-82.23%	-60.97%
Goodwill
YoY Change
Intangibles	$51.21M	$52.45M
YoY Change	-10.7%	-11.05%
Long-Term Investments
YoY Change
Other Assets	$1.971M	$2.229M	$2.229M
YoY Change	155.31%	181.44%	178.63%
Total Long-Term Assets	$55.09M	$56.20M	$56.20M
YoY Change	-11.55%	-11.67%	-11.77%
TOTAL ASSETS
Total Short-Term Assets	$60.74M	$61.89M	$61.89M
Total Long-Term Assets	$55.09M	$56.20M	$56.20M
Total Assets	$115.8M	$118.1M	$118.1M
YoY Change	-12.84%	-13.46%	-13.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.51M	$10.44M	$20.40M
YoY Change	-50.86%	-57.39%	-16.72%
Accrued Expenses	$33.72M	$38.57M	$29.32M
YoY Change	-17.2%	-17.58%	-20.75%
Deferred Revenue
YoY Change
Short-Term Debt	$4.270M	$2.395M	$2.395M
YoY Change	251.44%	53.23%	49.69%
Long-Term Debt Due	$1.857M	$1.857M	$1.857M
YoY Change	1757.0%	1757.0%	1757.0%
Total Short-Term Liabilities	$61.25M	$62.23M	$62.23M
YoY Change	-6.43%	-9.83%	-9.81%
LONG-TERM LIABILITIES
Long-Term Debt	$10.43M	$10.88M	$10.88M
YoY Change	-29.53%	-26.01%	-26.01%
Other Long-Term Liabilities	$4.921M	$4.529M	$17.27M
YoY Change	-39.29%	-35.07%	28.91%
Total Long-Term Liabilities	$24.75M	$28.15M	$28.15M
YoY Change	205.37%	303.6%	0.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$61.25M	$62.23M	$62.23M
Total Long-Term Liabilities	$24.75M	$28.15M	$28.15M
Total Liabilities	$86.01M	$90.38M	$90.38M
YoY Change	-14.61%	-6.93%	-6.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$318.5M	-$320.0M
YoY Change	2.02%	5.22%
Common Stock	$1.000K	$1.000K
YoY Change	-100.0%	-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$29.83M	$27.72M	$27.72M
YoY Change
Total Liabilities & Shareholders Equity	$115.8M	$118.1M	$118.1M
YoY Change	-12.84%	-13.46%	-13.48%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	$1.474M	-$4.617M	-$15.84M
YoY Change	-118.2%	87.68%	-7.35%
Depreciation, Depletion And Amortization	$1.427M	$1.944M	$8.272M
YoY Change	-36.01%	-8.3%	-6.16%
Cash From Operating Activities	-$1.190M	-$788.0K	-$1.388M
YoY Change	495.0%	-108.42%	-72.78%
INVESTING ACTIVITIES
Capital Expenditures	$136.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$517.0K	-$34.00K	$329.0K
YoY Change	580.26%	-78.75%	193.75%
Cash From Investing Activities	$381.0K	-$34.00K	-$329.0K
YoY Change	-601.32%	-78.75%	181.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$15.72M
YoY Change			16277.08%
Cash From Financing Activities	911.0K	1.068M	-$1.262M
YoY Change	-133.32%	-119.74%	-114.23%
NET CHANGE
Cash From Operating Activities	-1.190M	-788.0K	-$1.388M
Cash From Investing Activities	381.0K	-34.00K	-$329.0K
Cash From Financing Activities	911.0K	1.068M	-$1.262M
Net Change In Cash	102.0K	246.0K	-$2.979M
YoY Change	-103.38%	-93.51%	-182.18%
FREE CASH FLOW
Cash From Operating Activities	-$1.190M	-$788.0K	-$1.388M
Capital Expenditures	$136.0K
Free Cash Flow	-$1.326M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5972638
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5972638
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5517174
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5517174
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1004000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q2	aytu	Accounts Receivable Allowance For Pricing Chargebacks AccountsReceivableAllowanceForPricingChargebacks	1200000	usd
CY2024	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2024	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet
CY2024Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#LongTermDebtCurrent
CY2023Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#LongTermDebtCurrent
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q2	us-gaap	Goodwill Goodwill	0	usd
CY2023	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#AssetImpairmentCharges
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2024	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024	us-gaap	Impairment Intangible Asset Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentIntangibleAssetStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#AssetImpairmentCharges
CY2023	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#DerivativeGainLossOnDerivativeNet
CY2024	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#DerivativeGainLossOnDerivativeNet
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5972638
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5517174
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2024	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-38247
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-0883144
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	7900 East Union Avenue, Suite 920
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80237
CY2024	dei	City Area Code CityAreaCode	720
CY2024	dei	Local Phone Number LocalPhoneNumber	437-6580
CY2024	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2024	dei	Trading Symbol TradingSymbol	AYTU
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	10712951	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6148993
CY2024	dei	Auditor Firm AuditorFirmId	248
CY2024	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2024	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20006000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22985000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23617000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28937000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	12633000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	11995000	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5635000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7162000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	61891000	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	71079000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	693000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1815000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	829000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2054000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52453000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	58970000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2229000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2545000	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	56204000	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	65384000	usd
CY2024Q2	us-gaap	Assets Assets	118095000	usd
CY2023Q2	us-gaap	Assets Assets	136463000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	10440000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	13478000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38574000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	46799000	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	2395000	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1563000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1857000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	85000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8962000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7090000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	62228000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	69015000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10877000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14713000	usd
CY2024Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12745000	usd
CY2023Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	6403000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4529000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6975000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	28151000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	28091000	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	347688000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	343485000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-319973000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-304129000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	27716000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	39357000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118095000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	136463000	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	81002000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	107399000	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	26416000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	40767000	usd
CY2024	us-gaap	Gross Profit GrossProfit	54586000	usd
CY2023	us-gaap	Gross Profit GrossProfit	66632000	usd
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26958000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	41448000	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22514000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28630000	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2791000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4095000	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5212000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4788000	usd
CY2024	us-gaap	Restructuring Charges RestructuringCharges	2365000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5705000	usd
CY2024	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-969000	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	59840000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	83697000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-5254000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-17065000	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	568000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	184000	usd
CY2024	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4792000	usd
CY2023	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4963000	usd
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-4004000	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	4793000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14076000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17051000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1768000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-15844000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17051000	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5537957
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3339906
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.86
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.11
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	44308000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6046000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6054000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17051000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	39357000	usd
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2913000	usd
CY2024	aytu	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1290000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-15844000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	27716000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-15844000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17051000	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8272000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8815000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	2913000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	6046000	usd
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-4004000	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	4793000	usd
CY2024	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	597000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	559000	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	2270000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	2351000	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5705000	usd
CY2024	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-969000	usd
CY2024	aytu	Noncash Gain Loss On Extinguishment Of Debt NoncashGainLossOnExtinguishmentOfDebt	-400000	usd
CY2023	aytu	Noncash Gain Loss On Extinguishment Of Debt NoncashGainLossOnExtinguishmentOfDebt	-0	usd
CY2024	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-660000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7000	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5320000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7153000	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2908000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3609000	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1527000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-846000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2879000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2384000	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9567000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3605000	usd
CY2024	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-3847000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1872000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1388000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5129000	usd
CY2024	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	329000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	117000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-329000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-117000	usd
CY2024	aytu	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	3467000	usd
CY2023	aytu	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	15575000	usd
CY2024	aytu	Payments Of Fixed Payment Arrangements PaymentsOfFixedPaymentArrangements	2566000	usd
CY2023	aytu	Payments Of Fixed Payment Arrangements PaymentsOfFixedPaymentArrangements	4266000	usd
CY2024	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	832000	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-2250000	usd
CY2024	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15722000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	96000	usd
CY2024	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	13000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	0	usd
CY2024	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	273000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	92000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1262000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8871000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2979000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3625000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22985000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19360000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20006000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22985000	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	4039000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3812000	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1608000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	787000	usd
CY2023	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	147000	usd
CY2024Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	5600000	usd
CY2024	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3500000	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Use of Estimates</i></b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The preparation of financial statements and footnotes requires the use of management estimates, judgments and assumptions. Actual results <em style="font: inherit;"> may </em>differ from estimates. In the accompanying consolidated financial statements and notes thereto, estimates are used for, but <em style="font: inherit;">not</em> limited to, stock-based compensation; revenue recognition, determination of variable consideration for accruals of chargebacks, administrative fees and rebates, government rebates, returns and other allowances; allowance for credit losses; inventory impairment; determination of right-of-use assets and lease liabilities; valuation of financial instruments, derivative warrant liabilities, intangible assets, and long-lived assets; purchase price allocations and the depreciable lives of long-lived assets; accruals for contingent liabilities; and determination of the income tax provision, deferred taxes and valuation allowance.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"></p>
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Prior Period Reclassification</i></b><i>. </i></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Certain prior year amounts in the Company’s consolidated financial statements and the notes thereto have been reclassified to conform to the current year presentation. These reclassifications did <em style="font: inherit;">not</em> impact operating results or cash flows for the fiscal years ended <em style="font: inherit;"> June 30, 2024, </em>and <em style="font: inherit;">2023,</em> or its financial position as of <em style="font: inherit;"> June 30, 2024</em>, or <em style="font: inherit;"> June 30, 2023</em>.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Previously Reported Prepaid Expenses Information</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">During the year ended <em style="font: inherit;"> June 30, 2024, </em>the Company identified that certain of the Company’s prepaid expenses totaling $1.8 million that were previously reported as current assets as of <em style="font: inherit;"> June 30, 2023, </em>should have been classified as non-current assets as of <em style="font: inherit;"> June 30, 2023. </em>The Company assessed the materiality of this omission on the previously issued interim and annual consolidated financial statements in accordance with the United States Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin <em style="font: inherit;">No.</em> <em style="font: inherit;">99,</em> “Materiality” and concluded that the omission was <em style="font: inherit;">not</em> material to any of the previously issued consolidated financial statements and began reporting the prepaid expenses as non-current within this Form <em style="font: inherit;">10</em>-K.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"></p>
CY2024Q2	aytu	Accounts Receivable Allowance For Discounts AccountsReceivableAllowanceForDiscounts	600000	usd
CY2023Q2	aytu	Accounts Receivable Allowance For Discounts AccountsReceivableAllowanceForDiscounts	1800000	usd
CY2024Q2	aytu	Accounts Receivable Allowance For Pricing Chargebacks AccountsReceivableAllowanceForPricingChargebacks	1200000	usd
CY2022Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	24219000	usd
CY2023	aytu	Accounts Receivable Before Allowance For Credit Loss Period Increase Decrease AccountsReceivableBeforeAllowanceForCreditLossPeriodIncreaseDecrease	7708000	usd
CY2023Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	31927000	usd
CY2024	aytu	Accounts Receivable Before Allowance For Credit Loss Period Increase Decrease AccountsReceivableBeforeAllowanceForCreditLossPeriodIncreaseDecrease	-6488000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	25439000	usd
CY2022Q2	aytu	Accounts Receivable Allowance For Discounts AccountsReceivableAllowanceForDiscounts	1301000	usd
CY2022Q2	aytu	Accounts Receivable Allowance For Pricing Chargebacks AccountsReceivableAllowanceForPricingChargebacks	1206000	usd
CY2022Q2	aytu	Accounts Receivable Allowance For Pricing Chargebacks And Discounts AccountsReceivableAllowanceForPricingChargebacksAndDiscounts	2507000	usd
CY2023	aytu	Accounts Receivable Allowance For Discounts Credit Loss Expense Reversal AccountsReceivableAllowanceForDiscountsCreditLossExpenseReversal	9074000	usd
CY2023	aytu	Accounts Receivable Allowance For Pricing Chargebacks Credit Loss Expense Reversal AccountsReceivableAllowanceForPricingChargebacksCreditLossExpenseReversal	4554000	usd
CY2023	aytu	Accounts Receivable Allowance For Pricing Chargebacks And Discount Credit Loss Expense Reversal AccountsReceivableAllowanceForPricingChargebacksAndDiscountCreditLossExpenseReversal	13628000	usd
CY2023	aytu	Accounts Receivable Allowance For Discounts Recovery AccountsReceivableAllowanceForDiscountsRecovery	-8597000	usd
CY2023	aytu	Accounts Receivable Allowance For Pricing Chargebacks Recovery AccountsReceivableAllowanceForPricingChargebacksRecovery	-4548000	usd
CY2023	aytu	Accounts Receivable Allowance For Chargeback And Discounts Recovery AccountsReceivableAllowanceForChargebackAndDiscountsRecovery	13145000	usd
CY2023Q2	aytu	Accounts Receivable Allowance For Discounts AccountsReceivableAllowanceForDiscounts	1778000	usd
CY2023Q2	aytu	Accounts Receivable Allowance For Pricing Chargebacks AccountsReceivableAllowanceForPricingChargebacks	1212000	usd
CY2023Q2	aytu	Accounts Receivable Allowance For Pricing Chargebacks And Discounts AccountsReceivableAllowanceForPricingChargebacksAndDiscounts	2990000	usd
CY2024	aytu	Accounts Receivable Allowance For Discounts Credit Loss Expense Reversal AccountsReceivableAllowanceForDiscountsCreditLossExpenseReversal	4886000	usd
CY2024	aytu	Accounts Receivable Allowance For Pricing Chargebacks Credit Loss Expense Reversal AccountsReceivableAllowanceForPricingChargebacksCreditLossExpenseReversal	3812000	usd
CY2024	aytu	Accounts Receivable Allowance For Pricing Chargebacks And Discount Credit Loss Expense Reversal AccountsReceivableAllowanceForPricingChargebacksAndDiscountCreditLossExpenseReversal	8698000	usd
CY2024	aytu	Accounts Receivable Allowance For Discounts Recovery AccountsReceivableAllowanceForDiscountsRecovery	-6024000	usd
CY2024	aytu	Accounts Receivable Allowance For Pricing Chargebacks Recovery AccountsReceivableAllowanceForPricingChargebacksRecovery	-3842000	usd
CY2024	aytu	Accounts Receivable Allowance For Chargeback And Discounts Recovery AccountsReceivableAllowanceForChargebackAndDiscountsRecovery	9866000	usd
CY2024Q2	aytu	Accounts Receivable Allowance For Discounts AccountsReceivableAllowanceForDiscounts	640000	usd
CY2024Q2	aytu	Accounts Receivable Allowance For Pricing Chargebacks AccountsReceivableAllowanceForPricingChargebacks	1182000	usd
CY2024Q2	aytu	Accounts Receivable Allowance For Pricing Chargebacks And Discounts AccountsReceivableAllowanceForPricingChargebacksAndDiscounts	1822000	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Concentration of Credit Risk</i></b><i>. </i></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Financial instruments that potentially subject the Company to credit risk concentrations consist of cash, cash equivalents and accounts receivable.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Company maintains deposits in financial institutions in excess of federally insured limits. The Company periodically monitors the credit quality of the financial institutions with which it invests and believes that the Company is <em style="font: inherit;">not</em> exposed to significant credit risk due to the financial position of those institutions.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Company is also subject to credit risk from accounts receivable related to product sales. The Company’s customers, sometimes referred to as partners or customers, are primarily large wholesale distributors that resell the Company’s products to retailers. The loss of <em style="font: inherit;">one</em> or more of these large customers could have a material adverse effect on the Company’s business, operating results or financial condition. The Company does <em style="font: inherit;">not</em> charge interest or require collateral related to its accounts receivable. Credit terms are generally <span style="-sec-ix-hidden:c117047243">thirty</span> to <span style="-sec-ix-hidden:c117047245">sixty</span> days.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The following table presents customers that contributed more than <em style="font: inherit;">10%</em> of gross revenue and accounts receivable<i>: </i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 52%;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Percentage of Gross Revenue</em></em></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Percentage of Accounts Receivable</em></em></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 52%; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px;"> <p style="margin: 0pt; font-size: 10pt; font-family: "Times New Roman", Times, serif;"></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;"><em style="font: inherit;">June 30,</em></em></b></td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;"><em style="font: inherit;">June 30,</em></em></b></td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;"> </td></tr> <tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;">Customer A</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">33</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">43</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">40</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">50</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;">Customer B</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">20</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">18</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">29</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">19</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;">Customer C</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">17</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">17</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">11</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">14</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"></p>
CY2024	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	700000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1000000	usd
CY2024	us-gaap	Advertising Expense AdvertisingExpense	4900000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	17200000	usd
CY2024Q1	aytu	Employee Retention Credit Vendor Fee EmployeeRetentionCreditVendorFee	400000	usd
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6249554
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6636773
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	81002000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	107399000	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	81002000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	107399000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	266000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1301000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5725000	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2956000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6642000	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7738000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	12633000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	11995000	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	2300000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	2400000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2818000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5496000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2125000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3681000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	693000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1815000	usd
CY2024	us-gaap	Depreciation Depreciation	900000	usd
CY2023	us-gaap	Depreciation Depreciation	1300000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	100000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2024	us-gaap	Lease Cost LeaseCost	2397000	usd
CY2023	us-gaap	Lease Cost LeaseCost	1574000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	829000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2054000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	159000	usd
CY2024Q2	aytu	Operating Lease And Finance Lease Rightofuse Asset OperatingLeaseAndFinanceLeaseRightofuseAsset	829000	usd
CY2023Q2	aytu	Operating Lease And Finance Lease Rightofuse Asset OperatingLeaseAndFinanceLeaseRightofuseAsset	2213000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	712000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1258000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	85000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	577000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	832000	usd
CY2024Q2	aytu	Operating Lease And Finance Lease Liability OperatingLeaseAndFinanceLeaseLiability	1289000	usd
CY2023Q2	aytu	Operating Lease And Finance Lease Liability OperatingLeaseAndFinanceLeaseLiability	2175000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M12D
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M24D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.078	pure
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0	pure
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	1812000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1436000	usd
CY2024	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3000	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	9000	usd
CY2024	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	85000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	96000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	970000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	399000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	377000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	386000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	359000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	249000	usd
CY2024Q2	aytu	Lessee Operating Lease Liability To Be Paid Including Lease Not Yet Commenced LesseeOperatingLeaseLiabilityToBePaidIncludingLeaseNotYetCommenced	2740000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	555000	usd
CY2024Q2	aytu	Operating Lease Liability Including Lease Not Yet Commenced OperatingLeaseLiabilityIncludingLeaseNotYetCommenced	2185000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	71468000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19015000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52453000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P12Y
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	78583000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19613000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	58970000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P12Y8M12D
CY2024	aytu	Amortization Expense Of Intangible Assets AmortizationExpenseOfIntangibleAssets	6500000	usd
CY2023	aytu	Amortization Expense Of Intangible Assets AmortizationExpenseOfIntangibleAssets	6100000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4989000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4989000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4989000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4989000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4989000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	27508000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52453000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3000000	usd
CY2024Q2	aytu	Accrued Saving Offers AccruedSavingOffers	11054000	usd
CY2023Q2	aytu	Accrued Saving Offers AccruedSavingOffers	15739000	usd
CY2024Q2	aytu	Accrued Program Related Liabilities AccruedProgramRelatedLiabilities	9964000	usd
CY2023Q2	aytu	Accrued Program Related Liabilities AccruedProgramRelatedLiabilities	11012000	usd
CY2024Q2	aytu	Accrued Customer And Product Related Fees Current AccruedCustomerAndProductRelatedFeesCurrent	5395000	usd
CY2023Q2	aytu	Accrued Customer And Product Related Fees Current AccruedCustomerAndProductRelatedFeesCurrent	6579000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4935000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5675000	usd
CY2024Q2	aytu	Return Reserve Current ReturnReserveCurrent	4835000	usd
CY2023Q2	aytu	Return Reserve Current ReturnReserveCurrent	5777000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2391000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2017000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38574000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	46799000	usd
CY2024Q2	aytu	Fixed Payment Arrangements FixedPaymentArrangements	8337000	usd
CY2023Q2	aytu	Fixed Payment Arrangements FixedPaymentArrangements	10420000	usd
CY2024Q2	aytu	Employee Retention Credit EmployeeRetentionCredit	3759000	usd
CY2023Q2	aytu	Employee Retention Credit EmployeeRetentionCredit	0	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1289000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2090000	usd
CY2024Q2	us-gaap	Other Sundry Liabilities OtherSundryLiabilities	106000	usd
CY2023Q2	us-gaap	Other Sundry Liabilities OtherSundryLiabilities	1555000	usd
CY2024Q2	us-gaap	Other Liabilities OtherLiabilities	13491000	usd
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	14065000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8962000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7090000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4529000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6975000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13000000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	15000000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	266000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	925000	usd
CY2024Q2	aytu	Debt Instrument Final Payment DebtInstrumentFinalPayment	0	usd
CY2023Q2	aytu	Debt Instrument Final Payment DebtInstrumentFinalPayment	638000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	85000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	12734000	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	14798000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1857000	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	85000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10877000	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14713000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1857000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1857000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1857000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	7429000	usd
CY2024Q2	aytu	Long Term Debt And Capital Lease Obligations Gross LongTermDebtAndCapitalLeaseObligationsGross	13000000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	266000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1857000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10877000	usd
CY2024Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12745000	usd
CY2024Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	12745000	usd
CY2023Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	6403000	usd
CY2023Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	6403000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	5600000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1800000	usd
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.126	pure
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	300000	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	100000	usd
CY2023Q2	aytu	Operating Loss Carryforwards Limitations On Use Ownership Change Postchange Net Operating Loss Fully Available To Offset Current Fiscal Year Prechange Income Subject To Limitation OperatingLossCarryforwardsLimitationsOnUseOwnershipChangePostchangeNetOperatingLossFullyAvailableToOffsetCurrentFiscalYearPrechangeIncomeSubjectToLimitation	12000000	usd
CY2023Q2	aytu	Operating Loss Carryforwards Limitations On Use Ownership Change Postchange Net Operating Loss Disallowed Recognized Builtin Loss Carried Forward As Operating Loss OperatingLossCarryforwardsLimitationsOnUseOwnershipChangePostchangeNetOperatingLossDisallowedRecognizedBuiltinLossCarriedForwardAsOperatingLoss	300000	usd
CY2024Q2	aytu	Operating Loss Carryforwards Limitations On Use Ownership Change Postchange Net Operating Loss Disallowed Recognized Builtin Loss Carried Forward As Operating Loss OperatingLossCarryforwardsLimitationsOnUseOwnershipChangePostchangeNetOperatingLossDisallowedRecognizedBuiltinLossCarriedForwardAsOperatingLoss	8800000	usd
CY2024Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	519600000	usd
CY2024Q2	aytu	Operating Loss Carryforwards Not Subject To Expiration OperatingLossCarryforwardsNotSubjectToExpiration	186600000	usd
CY2024Q2	aytu	Operating Loss Carryforward Subject To Expire OperatingLossCarryforwardSubjectToExpire	333000000	usd
CY2024Q2	aytu	Operating Loss Carryforward Expirations Ownership Change OperatingLossCarryforwardExpirationsOwnershipChange	329200000	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1549000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	80000	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	219000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	46000	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1768000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	126000	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-109000	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-17000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-126000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1768000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2956000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3581000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-779000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.055	pure
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-430000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.025	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	19000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.001	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0	pure
CY2024	aytu	Income Tax Reconciliation Contingent Consideration IncomeTaxReconciliationContingentConsideration	0	usd
CY2024	aytu	Effective Income Tax Rate Reconciliation Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent	0	pure
CY2023	aytu	Income Tax Reconciliation Contingent Consideration IncomeTaxReconciliationContingentConsideration	-193000	usd
CY2023	aytu	Effective Income Tax Rate Reconciliation Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent	0.012	pure
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5447000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.387	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4087000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.24	pure
CY2024	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	37000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003	pure
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	117000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.007	pure
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1768000	usd
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.126	pure
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0	pure
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	119170000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	113819000	usd
CY2024Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	4845000	usd
CY2023Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	4188000	usd
CY2024Q2	aytu	Deferred Tax Assets Accrued Rebates DeferredTaxAssetsAccruedRebates	3819000	usd
CY2023Q2	aytu	Deferred Tax Assets Accrued Rebates DeferredTaxAssetsAccruedRebates	6994000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	3061000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	1504000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2416000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2416000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1259000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4250000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1027000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	758000	usd
CY2024Q2	aytu	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	780000	usd
CY2023Q2	aytu	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	836000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	256000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	743000	usd
CY2024Q2	aytu	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	305000	usd
CY2023Q2	aytu	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	492000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	99000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2024Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	975000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1332000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	138012000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	137332000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	137250000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	135954000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	762000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1378000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	563000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	845000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	199000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	483000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	-0	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	50000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	762000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1378000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	137300000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	136000000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1300000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2900000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2948000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2822000	usd
CY2024	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	1996000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	120000	usd
CY2024	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	361000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	246000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1313000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2948000	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5972638
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5517174
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	113500
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.74
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	49212
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	52762
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.37
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y1M6D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	113500
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.74
CY2024	aytu	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P9Y2M12D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	16610
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.2
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	3113
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	66.84
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	146539
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.18
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M18D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	25068
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	26.06
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y
CY2024Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	146539
CY2024Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	6.18
CY2024	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y9M18D
CY2024Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	25068
CY2024Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	225.74
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	0	usd
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y8M12D
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2913000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6046000	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6538052
CY2023	aytu	Class Of Warrant Or Right Weighted Average Remaining Contractual Life ClassOfWarrantOrRightWeightedAverageRemainingContractualLife	P4Y8M12D
CY2024	aytu	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1806434
CY2024	aytu	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	2247648
CY2024	aytu	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	20958
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6075880
CY2024	aytu	Class Of Warrant Or Right Weighted Average Remaining Contractual Life ClassOfWarrantOrRightWeightedAverageRemainingContractualLife	P3Y1M6D
CY2024	us-gaap	Restructuring Costs RestructuringCosts	3095000	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	81002000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-5254000	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7456000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	2913000	usd
CY2024	us-gaap	Restructuring Charges RestructuringCharges	2365000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	107399000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-17065000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7387000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	6046000	usd
CY2023	aytu	Asset Impairment And Writeoff Charges AssetImpairmentAndWriteoffCharges	5705000	usd

Files In Submission

Name	View Source	Status
0001437749-24-030062-index-headers.html	Edgar Link	pending
0001437749-24-030062-index.html	Edgar Link	pending
0001437749-24-030062.txt	Edgar Link	pending
0001437749-24-030062-xbrl.zip	Edgar Link	pending
aytu-20240630.xsd	Edgar Link	pending
aytu20240630_10k.htm	Edgar Link	pending
ex_622500.htm	Edgar Link	pending
ex_622502.htm	Edgar Link	pending
ex_622504.htm	Edgar Link	pending
aytu-20240630_cal.xml	Edgar Link	unprocessable
aytu-20240630_def.xml	Edgar Link	unprocessable
aytu-20240630_lab.xml	Edgar Link	unprocessable
aytu-20240630_pre.xml	Edgar Link	unprocessable
aytu20240630_10k_htm.xml	Edgar Link	completed
ex_622505.htm	Edgar Link	pending
ex_622506.htm	Edgar Link	pending
ex_707455.htm	Edgar Link	pending
ex_721289.htm	Edgar Link	pending
ex_721858.htm	Edgar Link	pending
ex_726135.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image01.jpg	Edgar Link	pending
image02.jpg	Edgar Link	pending
image03.jpg	Edgar Link	pending
image04.jpg	Edgar Link	pending
image05.jpg	Edgar Link	pending
image06.jpg	Edgar Link	pending
image07.jpg	Edgar Link	pending
image08.jpg	Edgar Link	pending
jwb01.jpg	Edgar Link	pending
logo01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
seal01.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AYTU
AYTU BIOPHARMA, INC Stock $aytu

2024 Q3 Form 10-K Financial Statement

#000143774924030062 Filed on September 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU AYTU BIOPHARMA, INC Stock $aytu

2024 Q3 Form 10-K Financial Statement

#000143774924030062 Filed on September 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU
AYTU BIOPHARMA, INC Stock $aytu